BioLineRx (BLRX) Receivables - Other (2010 - 2026)
BioLineRx's Receivables - Other came in at $728,000 for the quarter ended Jun 30, 2026, up 258.6% from $203,000 a year earlier but down 61.5% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Receivables - Other (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Receivables - Other was $820,000, down 72.3% from the prior year.
- Receivables - Other carries a five-year compound annual growth rate of 23.8% (years ended Dec 2020 to Dec 2025).
- Going back by year, Receivables - Other was $2.96 million in the year ended Dec 31, 2024 (+78.1%), $1.66 million in the year ended Dec 31, 2023 (+15.1%), $1.44 million in the year ended Dec 31, 2022 (+407.7%) and $284,000 in the year ended Dec 31, 2021 (+0.7%).
- The five-year range for quarterly Receivables - Other is $128,000 (the quarter ended Jun 30, 2023) to $2.96 million (the quarter ended Dec 31, 2024).
- Year-over-year, Receivables - Other increased in five of the last eight quarters, with growth averaging 75.2%.
- The fastest year-over-year change in Receivables - Other over five years came in the quarter ended Jun 30, 2024 (growth of 412.5%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 84.6%).
- Business Quant data shows BLRX's Receivables - Other at $1.89 million (quarter ended Mar 31, 2026), $456,000 (quarter ended Dec 31, 2025) and $699,000 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 728,000.00 |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 456,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 315,000.00 |
| Jun 30, 2023 | 128,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | 143,000.00 |
| Jun 30, 2022 | 240,000.00 |
| Mar 31, 2022 | 190,000.00 |
| Dec 31, 2021 | 284,000.00 |
| Sep 30, 2021 | 192,000.00 |
API Access
BioLineRx Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();